Market Research Logo

EpiCast Report: Endometriosis - Epidemiology Forecast to 2025

EpiCast Report: Endometriosis - Epidemiology Forecast to 2025

Summary

Endometriosis is an estrogen-dependent disorder characterized by growth and appearance of endometrial cells or tissues in locations outside the uterus, which results in a series of chronic inflammatory reactions leading to scarring of tissues and adhesions of fibrous tissues in the pelvic region. The condition is often associated with severe dysmenorrhea, chronic pelvic pain, chronic fatigue, deep dyspareunia, ovulation pain, abnormal bleeding, and infertility. Endometriosis has the potential to disrupt the quality of life of women, leading to emotional distress, loss of work productivity, physical limitations, and social withdrawal.

This report also provides diagnosed incident and prevalent cases of endometriosis segmented by laparoscopy confirmation status (laparoscopy-confirmed or suspected without laparoscopy). The laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further classified according to endometriosis staging system developed by the American Society for Reproductive Medicine (ASRM) into stage I (minimal), stage II (mild), stage III (moderate), and stage IV (severe). In addition, the laparoscopy-confirmed diagnosed prevalent cases of endometriosis are segmented by phenotypes into superficial peritoneal endometriosis (SUP), ovarian endometrioma (OMA), and deeply infiltrating endometriosis (DIE). The laparoscopy-confirmed diagnosed incident and laparoscopy-confirmed diagnosed prevalent cases of endometriosis are further segmented by age.

In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed incident cases of endometriosis will increase from 251,010 cases in 2015 to 253,620 cases in 2025 at an Annual Growth Rate (AGR) of 0.10%. In the 7MM, GlobalData epidemiologists forecast that the laparoscopy-confirmed diagnosed prevalent cases of endometriosis will increase from 6,160,839 cases in 2015 to 6,217,079 cases in 2025 at an AGR of 0.09%.

GlobalData epidemiologists utilized comprehensive, country-specific data from peer-reviewed journal articles, and primary research to arrive at a meaningful, in-depth analysis and forecast for laparoscopy-confirmed diagnosed incident cases of endometriosis, as well as laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Finally, the same forecast methodology was used across the 7MM, thereby allowing for meaningful global comparisons of laparoscopy-confirmed diagnosed incident cases, and laparoscopy-confirmed diagnosed prevalent cases of endometriosis across these markets.

Scope

  • The Endometriosis EpiCast Report provides an overview of the risk factors and global trends of endometriosis in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the laparoscopy-confirmed diagnosed incident cases of endometriosis and a 10-year forecast of laparoscopy-confirmed diagnosed prevalent cases of endometriosis. Additional segmentations of patient populations are also available.
  • The endometriosis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
  • The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Reasons to buy

The Endometriosis EpiCast report will allow you to -
  • Develop business strategies by understanding the trends shaping and driving the global endometriosis market.
  • Quantify patient populations in the global endometriosis market to improve product design, pricing, and launch plans.
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for endometriosis therapeutics in each of the markets covered.
  • Identify the distribution of endometriosis prevalent cases by phenotypes and stage.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Epidemiology
2.1 Disease Background
2.2 Risk Factors and Comorbidities
2.3 Global Trends
2.3.1 US
2.3.2 5EU
2.3.3 Japan
2.4 Forecast Methodology
2.4.1 Sources Used Tables
2.4.2 Forecast Assumptions and Methods
2.4.3 Sources Not Used
2.5 Epidemiological Forecast for Endometriosis (2015-2025)
2.5.1 Diagnosed Incident Cases
2.5.2 Diagnosed Prevalent Cases
2.6 Discussion
2.6.1 Epidemiological Forecast Insight
2.6.2 Limitations of the Analysis
2.6.3 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 Physicians and Specialists Included in this Study
3.3 About the Authors
1.1.1 Epidemiologists
3.3.1 Reviewers
3.3.2 Global Director of Therapy Analysis and Epidemiology
3.4 About GlobalData
3.5 About EpiCast
3.6 Disclaimer
1.1 List of Tables
Table 1: Risk Factors and Comorbidities for Endometriosis
Table 2: Stages of Endometriosis According to the American Society for Reproductive Medicine Criteria
Table 3: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Incident Cases of Endometriosis
Table 4: 7MM, Sources of Epidemiological Data Used for the Forecast of Laparoscopy Confirmed Diagnosed Prevalent Cases of Endometriosis
Table 5: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the ASRM Stages I-IV
Table 6: 7MM, Sources of Epidemiological Data Used for the Classification of Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis According to the Phenotype
Table 7: Sources Used to Forecast Laparoscopy Confirmation Status for Diagnosed Incident Cases and Diagnosed Prevalent Cases of Endometriosis
Table 8: 7MM, Sources Not Used in Epidemiological Analysis of Endometriosis
Table 9: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
Table 10: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Women, N (Row %), 2015
Table 11: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
Table 12: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N (Row %), 2015
Table 13: High-Prescribing Physicians (Non-KOLs), Surveyed by Country, 2016
1.2 List of Figures
Figure 1: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
Figure 2: 7MM, Laparoscopy-Confirmed Diagnosed Incident Cases of Endometriosis by Age Group, Women, N, 2015
Figure 3: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Incidence of Endometriosis (Cases per 100,000 Population), Ages 12-54 Years, Women, 2015
Figure 4: 7MM, Diagnosed Incident Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12-54 Years, Women, N, 2015
Figure 5: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Ages 12-54 Years, Women, N, 2015-2025
Figure 6: 7MM, Age-Specific Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis, Women, N, 2015
Figure 7: 7MM, Age-Standardized Laparoscopy-Confirmed Diagnosed Prevalence of Endometriosis (%), Ages 12-54 Years, Women, 2015
Figure 8: 7MM, Diagnosed Prevalent Cases of Endometriosis Segmented by Laparoscopy Confirmation Status, Ages 12-54 Years, Women, N, 2015
Figure 9: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by ASRM Disease Stages, Ages 12-54 Years, Women, N, 2015
Figure 10: 7MM, Laparoscopy-Confirmed Diagnosed Prevalent Cases of Endometriosis Segmented by Phenotype, Ages 12-54 Years, Women, N, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report